Drug Trial Radar · NCT04435990
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Last checked: Nov 20, 2026Latest source record: May 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Oct 6, 2020
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Inmunotek S.L.Industry
- Sponsor type
- Industry
- Collaborators
- BioClever 2005 S.L.
- First posted
- Jun 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A double-blinded, placebo-controlled, prospective, multicenter randomized of 2 active treatment groups, compared to 1 placebo group, for the determination of the efficacy and safety of subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophagoides farinae.
Conditions
- Rhinitis, Allergic
- Rhinoconjunctivitis
- Asthma, Allergic
Interventions
10,000 MM09Biological
Purified allergenic extract, and adsorbed in aluminum hydroxide and polymerized with glutaraldehyde, mite mixture (Dermatophagoides pteronyssinus and Dermatophagoides farinae) with a concentration of 10,000 UT / mL
30,000 MM09Biological
Purified allergenic extract, and adsorbed in aluminum hydroxide and polymerized with glutaraldehyde, mite mixture (Dermatophagoides pteronyssinus and Dermatophagoides farinae). The concentration is 30,000 UT / mL
Placebo subcutaneousBiological
The same solution and presentation as the active treatment, but without active ingredients.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CSMS: Combined Symptoms and Medication ScoreTime frame: 12 months
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Hospital General Universitario Dr. Balmis
Alicante, Spain · Recruiting
Hospital Universitario San Juan de Alicante
Alicante, Spain · Recruiting
Clínica Dermatológica y Alergia
Badajoz, Spain · Recruiting
Hospital Quironsalud Clideba
Badajoz, Spain · Recruiting
Hospital Sant Pere Claver
Barcelona, Spain · Recruiting
Clínica Corachan
Barcelona, Spain · Recruiting
Hospital Universitari Dexeus
Barcelona, Spain · Recruiting
Cenvi Medic
Barcelona, Spain · Recruiting
Allergocenter
Barcelona, Spain · Active not recruiting
Clinica privada
Bilbao, Spain · Withdrawn
Centro Médico ASISA Dr. Lobatón
Cadiz, Spain · Recruiting
Centro Médico Puerto
Cadiz, Spain · Recruiting
Hospital Quiron Salud Córdoba
Córdoba, Spain · Recruiting
Hospital Polusa
Lugo, Spain · Recruiting
Clinica privada
Málaga, Spain · Recruiting
Hospital Comarcal de Melilla
Melilla, Spain · Recruiting
Clinica Privada
Murcia, Spain · Not yet recruiting
Alergocantabria
Santander, Spain · Recruiting
Hospital Quiron Infanta Luisa
Seville, Spain · Recruiting
Clinica Lanuza
Valencia, Spain · Recruiting
Hospital Universitario Y Politecnico La Fe
Valencia, Spain · Recruiting
Clinica IMED
Valencia, Spain · Withdrawn
Hospital de Sagunto
Valencia, Spain · Withdrawn
Hospital Provincial de Conxo
Santiago de Compostela, A Coruña, Spain · Recruiting
IMED Elche
Elche, Alicante, Spain · Recruiting
Hospital Universitario de Torrevieja
Torrevieja, Alicante, Spain · Recruiting
Clinica Tecma
Valencia, Alzira, Spain · Completed
Clinica Virgen del Rosario
Algeciras, Cadiz, Spain · Active not recruiting
Hospital HLA Jerez Puerta Sur
Jerez de la Frontera, Cádiz, Spain · Withdrawn
Hospital Dr. Peset
Valencia, España, Spain · Recruiting
Hospital General Universitario Santa Maria de Rosell
Cartagena, Murcia, Spain · Withdrawn
Hospital Rivera Povisa
Vigo, Pontevedra, Spain · Active not recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.